Tessera Therapeutics
Aaron Zannini is a Chemical Engineering professional with experience in various pharmaceutical companies such as Ultragenyx Pharmaceutical Inc., Cue Biopharma, and TCR² Therapeutics Inc. Aaron has expertise in downstream operations, purification, cell line generation, assay development, and lab equipment maintenance. Aaron's work involves optimizing processes, generating critical data sets, and ensuring product stability. Aaron has demonstrated leadership abilities, technical skills, and a commitment to continuous process improvement throughout their career.
Tessera Therapeutics
3 followers
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.